These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 8375123)
1. Disposition of morphine and its glucuronide metabolites after oral and rectal administration: evidence of route specificity. Babul N; Darke AC Clin Pharmacol Ther; 1993 Sep; 54(3):286-92. PubMed ID: 8375123 [TBL] [Abstract][Full Text] [Related]
2. The influence of the route of administration: a comparative study at steady state of oral sustained release morphine and morphine sulfate suppositories. Du X; Skopp G; Aderjan R Ther Drug Monit; 1999 Apr; 21(2):208-14. PubMed ID: 10217341 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of morphine and its glucuronides following intravenous administration of morphine in patients undergoing continuous ambulatory peritoneal dialysis. Pauli-Magnus C; Hofmann U; Mikus G; Kuhlmann U; Mettang T Nephrol Dial Transplant; 1999 Apr; 14(4):903-9. PubMed ID: 10328468 [TBL] [Abstract][Full Text] [Related]
4. The pharmacokinetics of morphine and morphine glucuronide metabolites after subcutaneous bolus injection and subcutaneous infusion of morphine. Stuart-Harris R; Joel SP; McDonald P; Currow D; Slevin ML Br J Clin Pharmacol; 2000 Mar; 49(3):207-14. PubMed ID: 10718775 [TBL] [Abstract][Full Text] [Related]
5. Morphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6-glucuronide, and morphine-3-glucuronide. Klimas R; Mikus G Br J Anaesth; 2014 Dec; 113(6):935-44. PubMed ID: 24985077 [TBL] [Abstract][Full Text] [Related]
6. Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer-related pain. Quigley C; Joel S; Patel N; Baksh A; Slevin M Palliat Med; 2003 Mar; 17(2):185-90. PubMed ID: 12701850 [TBL] [Abstract][Full Text] [Related]
7. The bioavailability and pharmacokinetics of subcutaneous, nebulized and oral morphine-6-glucuronide. Penson RT; Joel SP; Roberts M; Gloyne A; Beckwith S; Slevin ML Br J Clin Pharmacol; 2002 Apr; 53(4):347-54. PubMed ID: 11966664 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and efficacy of rectal versus oral sustained-release morphine in cancer patients. Wilkinson TJ; Robinson BA; Begg EJ; Duffull SB; Ravenscroft PJ; Schneider JJ Cancer Chemother Pharmacol; 1992; 31(3):251-4. PubMed ID: 1464164 [TBL] [Abstract][Full Text] [Related]
9. Concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide in serum and cerebrospinal fluid following morphine administration to patients with morphine-resistant pain. Goucke RC; Hackett PL; Ilett KF Pain; 1994 Feb; 56(2):145-149. PubMed ID: 8008404 [TBL] [Abstract][Full Text] [Related]
10. Morphine pharmacokinetics and metabolism in humans. Enterohepatic cycling and relative contribution of metabolites to active opioid concentrations. Hasselström J; Säwe J Clin Pharmacokinet; 1993 Apr; 24(4):344-54. PubMed ID: 8491060 [TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy, safety and pharmacokinetics of a newly developed controlled release morphine sulphate suppository in patients with cancer pain. Moolenaar F; Meijler WJ; Frijlink HW; Visser J; Proost JH Eur J Clin Pharmacol; 2000 Jun; 56(3):219-23. PubMed ID: 10952476 [TBL] [Abstract][Full Text] [Related]
12. Rectal administration of morphine in children. Pharmacokinetic evaluation after a single-dose. Lundeberg S; Beck O; Olsson GL; Boreus LO Acta Anaesthesiol Scand; 1996 Apr; 40(4):445-51. PubMed ID: 8738689 [TBL] [Abstract][Full Text] [Related]
13. Influence of renal failure on the disposition of morphine, morphine-3-glucuronide and morphine-6-glucuronide in sheep during intravenous infusion with morphine. Milne RW; McLean CF; Mather LE; Nation RL; Runciman WB; Rutten AJ; Somogyi AA J Pharmacol Exp Ther; 1997 Aug; 282(2):779-86. PubMed ID: 9262341 [TBL] [Abstract][Full Text] [Related]
14. Morphine and morphine metabolite concentrations in cerebrospinal fluid and plasma in cancer pain patients after slow-release oral morphine administration. Wolff T; Samuelsson H; Hedner T Pain; 1995 Aug; 62(2):147-154. PubMed ID: 8545139 [TBL] [Abstract][Full Text] [Related]
15. A Compartmental Analysis for Morphine and Its Metabolites in Young Children After a Single Oral Dose. Velez de Mendizabal N; Jimenez-Mendez R; Cooke E; Montgomery CJ; Dawes J; Rieder MJ; Aleksa K; Koren G; Jacobo-Cabral CO; Gonzalez-Ramirez R; Castañeda-Hernandez G; Carleton BC Clin Pharmacokinet; 2015 Oct; 54(10):1083-90. PubMed ID: 25773480 [TBL] [Abstract][Full Text] [Related]
16. The effect of old age on the disposition and antinociceptive response of morphine and morphine-6 beta-glucuronide in the rat. Van Crugten JT; Somogyi AA; Nation RL; Reynolds G Pain; 1997 Jun; 71(2):199-205. PubMed ID: 9211481 [TBL] [Abstract][Full Text] [Related]
17. Influences on serum concentrations of morphine, M6G and M3G during routine clinical drug monitoring: a prospective survey in 300 adult cancer patients. Klepstad P; Dale O; Kaasa S; Zahlsen K; Aamo T; Fayers P; Borchgrevink PC Acta Anaesthesiol Scand; 2003 Jul; 47(6):725-31. PubMed ID: 12803591 [TBL] [Abstract][Full Text] [Related]
19. A Prospective Population Pharmacokinetic Study on Morphine Metabolism in Cancer Patients. Oosten AW; Abrantes JA; Jönsson S; Matic M; van Schaik RHN; de Bruijn P; van der Rijt CCD; Mathijssen RHJ Clin Pharmacokinet; 2017 Jul; 56(7):733-746. PubMed ID: 27815868 [TBL] [Abstract][Full Text] [Related]
20. Comparative disposition of morphine-3-glucuronide during separate intravenous infusions of morphine and morphine-3-glucuronide in sheep. Importance of the kidney. Milne RW; McLean CF; Mather LE; Nation RL; Runciman WB; Rutten AJ; Somogyi AA Drug Metab Dispos; 1995 Mar; 23(3):334-42. PubMed ID: 7628298 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]